Cyteir Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYT and other ETFs, options, and stocks.

About CYT

Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. 

CEO
Markus F. Renschler
CEOMarkus F. Renschler
Employees
40
Employees40
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2012
Founded2012
Employees
40
Employees40

CYT Key Statistics

Market cap
70.47M
Market cap70.47M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
42.38K
Average volume42.38K
High today
$2.00
High today$2.00
Low today
$1.89
Low today$1.89
Open price
$1.96
Open price$1.96
Volume
29.34K
Volume29.34K
52 Week high
$19.84
52 Week high$19.84
52 Week low
$1.56
52 Week low$1.56

CYT Earnings

-$4.83
-$3.22
-$1.61
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, After Hours
ActualExpected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.